Targeted editing of therapeutic genes using DNA-based transcriptional activators: Scope and challenges

Chemical Biology of Nucleic Acids: Fundamentals and Clinical Applications

Volumn , Issue , 2014, Pages 347-365

  Pandian, Ganesh N ^a   Sugiyama, Hiroshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Genome editing; Multifunctional molecules; TALENs; Transcription activators; Transcription factor based disorders

Indexed keywords

EID: 84986271330     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-54452-1_19     Document Type: Chapter

References (89)

1. Amir RE, Van den Veyver IB, Wan M et al (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185-188
2. Baker M (2012) Gene-editing nucleases. Nat Methods 9:23-26
3. Barbieri CE, Baca SC, Lawrence MS et al (2012) Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 44:685-689
4. Beffert U, Weeber EJ, Durudas A et al (2005) Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 47:567-579
5. Bilu Y, Barkai N (2005) The design of transcription-factor binding sites is affected by combinatorial regulation. Genome Biol 6:R103
6. Bogdanove AJ, Schornack S, Lahaye T (2010) TAL effectors: finding plant genes for disease and defense. Curr Opin Plant Biol 13:394-401
7. Burnett R, Melander C, Puckett JW et al (2006) DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA-TTC repeats in Friedreich’s ataxia. Proc Natl Acad Sci U S A 103:11497-11502
8. Ceol CJ, Houvras Y, Jane-Valbuena J et al (2011) The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 471:513-517
9. Chenoweth DM, Meier JL, Dervan PB (2013) Pyrrole-Imidazole polyamides distinguish between double-helical DNA and RNA. Angew Chem Int Ed 52:415-418
10. Chi Y, Huddleston MJ, Zhang X et al (2001) Negative regulation of Gcn4 and Msn2 transcription factors by Srb10 cyclin-dependent kinase. Genes Dev 15:1078-1092
11. Cloud J (2010) Why your DNA isn’t your destiny. Time Mag 61:175-189
12. Conaway RC, Conaway JW (2011) Function and regulation of the mediator complex. Curr Opin Genet Dev 21:225-230
13. Dawson MA, Kouzarides T (2012) Cancer epigenetics: from mechanism to therapy. Cell 150:1227
14. Dickinson LA, Trauger JW, Baird EE et al (1999) Anti-repression of polymerase II transcription by a designed ligand. Biochemistry 38:10801-10807
15. Durrin LK, Mann RK, Grunstein M (1992) Nucleosome loss activates CUP1 and HIS3 promoters to fully induced levels in the yeast Saccharomyces cerevisiae. Mol Cell Biol 12:1621-1629
16. Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301:89-92
17. Frances MB, Mukund T, Satyajit M (2012) Evolutionary cell biology: lessons from diversity. Nat Cell Biol 14:651
18. Goh YS, Grants JM (2012) Mutations in the mediator subunit MED23 link intellectual disability to immediate early gene regulation. Clin Genet 81:430-432
19. Grueter CE, van Rooij E, Johnson BA et al (2012) A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 149:671-683
20. Hamm CA, Costa FF (2011) The impact of epigenomics on future drug design and new therapies. Drug Discov Today 16:626-635
21. Han L, Pandian GN, Junetha S et al (2013) A synthetic small molecule for targeted transcriptional activation of germ cell genes in a human somatic cell. Angew Chem Int Ed. doi: 10.1002/anie.201306766
22. He A, Kong SW, Ma Q et al (2011) Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc Natl Acad Sci USA 108:5632-5637
23. Hockemeyer D, Wang H, Kiani S et al (2011) Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 29:731-734
24. Iwakuma T, Lozano G, Flores ER (2005) Li-Fraumeni syndrome: a p53 family affair. Cell Cycle 4:865-867
25. Jacob F, Monod J (1961) Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol 3:318-356
26. Jiang YH, Bressler J, Beaudet AL (2004) Epigenetics and human disease. Annu Rev Genomics Hum Genet 5:479-510
27. Joung JK, Sander JD (2013) TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14:49-55
28. Kalin JH, Butler KV, Kozikowski AP (2009) Creating zinc monkey wrenches in the treatment of epigenetic disorders. Curr Opin Chem Biol 13:263-271
29. Kashiwazaki G, Bando T, Yoshidome T et al (2012) Synthesis and biological properties of highly sequence specific-alkylating N-methylpyrrole-N-methylimidazole polyamide conjugates. J Med Chem 55:2057-2066
30. Keaveney M, Struhl K (1998) Activator-mediated recruitment of the RNA polymerase II machinery is the predominant mechanism for transcriptional activation in yeast. Mol Cell 1:917-924
31. Lai CSL, Fisher SE, Hurst JA et al (2001) A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 413:519-523
32. Lamb MJ, Jablonka E (2005) Evolution in four dimensions: genetic, epigenetic, behavioral, and symbolic variation in the history of life. MIT Press, Cambridge, MA, pp 5-34
33. Lee LW, Mapp AK (2010) Transcriptional switches: chemical approaches to gene regulation. J Biol Chem 285:11033-11038
34. Lee TI, Young RA (2013) Transcriptional regulation and its misregulation in disease. Cell 152:1237-1251
35. Li J, Chen C, Chen C et al (2011) Neurotensin receptor 1 gene (NTSR1) polymorphism is associated with working memory. PLoS ONE 6(3):e17365
36. Lin CY, Loven J, Rahl PB et al (2012) Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151:56-67
37. Liu XY, Wang J, Zheng JH et al (2011) Involvement of a novel GATA4 mutation in atrial septal defects. Int J Mol Med 28:17-23
38. Luo Z, Lin C, Guest E et al (2012) The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output. Mol Cell Biol 32:2608-2617
39. Maestro MA, Cardalda C, Boj SF et al (2007) Distinct roles of HNF1beta, HNF1alpha, and HNF4alpha in regulating pancreas development, beta-cell function and growth. Endocr Dev 12:33-45
40. Majmudar CY, Lum JK, Prasov L et al (2005) Functional specificity of artificial transcriptional activators. Chem Biol 12:313-321
41. Mak AN, Bradley P, Cernadas RA et al (2012) The crystal structure of TAL effector PthXo1 bound to its DNA target. Science 335:716-719
42. Mannini L, Musio A (2011) The dark side of cohesin: the carcinogenic point of view. Mutat Res 728:81-87
43. Mapp AK, Ansari AZ, Ptashne M et al (2000) Activation of gene expression by small molecule transcription factors. Proc Natl Acad Sci USA 97:3930-3935
44. Masuda S, Wu J, Hishida T et al (2013) Chemically induced pluripotent stem cells (CiPSCs): a transgene-free approach. J Mol Cell Biol 5:354-355
45. Maurano MT, Humbert R, Rynes E et al (2012) Systematic localization of common disease-associated variation in regulatory DNA. Science 337:1190-1195
46. McCulley DJ, Black BL (2012) Transcription factor pathways and congenital heart disease. Curr Top Dev Biol 100:253-277
47. Meier JL, Montgomery DC, Dervan PB (2012) Enhancing the cellular uptake of Py-Im polyamides through next-generation aryl turns. Nucleic Acids Res 40:2345-2356
48. Mercer AC, Gaj T, Fuller RP (2012) Chimeric TALE recombinases with programmable DNA sequence specificity. Nucleic Acids Res 40:11163-11172
49. Miller JC, Tan S, Qiao G et al (2011) A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29:143-148
50. Min JW, Haegeman G, Ysebaert M et al (1972) Nucleotide sequence of the gene coding for the bacteriophage MS2 coat protein. Nature 237:82-88
51. Minichiello L (2009) TrkB signalling pathways in LTP and learning. Nat Rev Neurosci 10:850-860
52. Mussolino C, Morbitzer R, Liitge F et al (2011) A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res 39:9283-9293
53. Odom DT, Zizlsperger N, Gordon DB et al (2004) Control of pancreas and liver gene expression by HNF transcription factors. Science 303:1378-1381
54. Ohtsuki A, Kimura MT, Minoshima M et al (2009) Synthesis and properties of PI polyamide-SAHA conjugate. Tetrahedron Lett 50:7288-7292
55. Olson EN (2006) Gene regulatory networks in the evolution and development of the heart. Science 313:1922-1927
56. Ouyang P, Saarel E, Bai Y et al (2011) A de novo mutation in NKX2.5 associated with atrial septal defects, ventricular noncompaction, syncope and sudden death. Clin Chim Acta 412:170-175
57. Pandian GN, Sugiyama H (2012) Programmable genetic switches to control transcriptional machinery of pluripotency. Biotechnol J 7:798-809
58. Pandian GN, Sugiyama H (2013) Strategies to modulate heritable epigenetic defects in cellular machinery: lessons from nature. Pharmaceuticals 6:1-24
59. Pandian GN, Shinohara K, Ohtsuki A et al (2011) Synthetic small molecules for epigenetic activation of pluripotency genes in mouse embryonic fibroblasts. ChemBioChem 12:2822-2828
60. Pandian GN, Ohtsuki A, Bando T et al (2012a) Development of programmable small DNA-binding molecules with epigenetic activity for induction of core pluripotency genes. Bioorg Med Chem 20(8):2656-2660
61. Pandian GN, Nakano Y, Sato S et al (2012b) A synthetic small molecule for rapid induction of multiple pluripotency genes in mouse embryonic fibroblast. Sci Rep 2:e544
62. Pandian GN, Taniguchi J, Junetha S et al (2014) Distinct DNA-based epigenetic switches trigger transcriptional activation of silent genes in human dermal fibroblasts. Sci Rep 4:e3843
63. Perez EE, Wang J, Miller JC et al (2008) Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26:808-816
64. Pfeifer A, Verma IM (2001) Gene therapy: promises and problems. Annu Rev Genomics Hum Genet 2:177-211
65. Ptashne M, Gann A (2002) Genes and signals. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
66. Rando OJ (2012) Combinatorial complexity in chromatin structure and function: revisiting the histone code. Curr Opin Genet Dev 22:148-155
67. Reyon D, Tsai SQ, Khayter C et al (2012) FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol 30:460-465
68. Robinson KM, Kadonaga JT (1998) The use of chromatin templates to recreate transcriptional regulatory phenomena in vitro. Biochim Biophys Acta 1378:1-6
69. Rump P, Niessen RC, Verbruggen KT et al (2011) A novel mutation in MED12 causes FG syndrome (OpitzKaveggia syndrome). Clin Genet 79:183-188
70. Ryan MM, Ryan B, Smith MK et al (2012) Temporal profiling of gene networks associated with the late phase of long-term potentiation in vivo. PLoS ONE 7:e40538
71. Saha A, Pandian GN, Sato S et al (2013) Synthesis and biological evaluation of a targeted DNA-binding transcriptional activator with HDAC8 inhibitory activity. Bioorg Med Chem 21:4201-4209
72. Sanda T, Lawton LN, Barrasa MI et al (2012) Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell 22:209-221
73. Santen GW, Kriek M, van Attikum H (2012) SWI/SNF complex in disorder: Switching from malignancies to intellectual disability. Epigenetics 7:1219-1224
74. Schreiber SL (2005) Nat Chem Biol 1:64-66
75. Sebastiano V, Maeder ML, Angstman JF et al (2011) In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases. Stem Cells 29:1717-1726
76. Seitan VC, Merkenschlager M (2012) Cohesin and chromatin organisation. Curr Opin Genet Dev 22:93-100
77. Shimogawa H, Kwon Y, Mao Q et al (2004) A wrench-shaped synthetic molecule that modulates a transcription factor-coactivator interaction. J Am Chem Soc 126:3461-3471
78. Soldner F, Laganiere J, Cheng AW et al (2011) Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146:318-331
79. Sun N, Zhao H (2013) Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing. Biotechnol Bioeng 110:1811-1821
80. Swaby JA, Silversides CK, Bekeschus SC et al (2011) Complex congenital heart disease in unaffected relatives of adults with 22q11.2 deletion syndrome. Am J Cardiol 107:466-471
81. Synold TW, Xi B, Wu J et al (2012) Single-dose pharmacokinetic and toxicity analysis of pyrrole-imidazolepolyamides in mice. Cancer Chemother Pharmacol 70:617-625
82. Thandavarayan RA, Giridharan VV, Sari FR et al (2011) Depletion of 14-3-3 protein exacerbates cardiac oxidative stress, inflammation and remodeling process via modulation of MAPK/NF-kB signaling pathways after streptozotocin-induced diabetes mellitus. Cell Physiol Biochem 28:911-922
83. Trauger JW, Baird EE, Dervan PB (1998) Recognition of 16 base Pairs in the minor groove of DNA by a pyrrole-imidazole polyamide dimer. J Am Chem Soc 120:3534-3535
84. Vaijayanthi T, Bando T, Pandian GN et al (2012) Progress and prospects of pyrrole-imidazole polyamide-fluorophore conjugates as sequence-selective DNA probes. ChemBioChem 13:2170-2185
85. Vaijayanthi T, Bando T, Hashiya K et al (2013) Design of a new fluorescent probe: pyrrole/imidazole hairpin polyamides with pyrene conjugation at their y-turn. Bioorg Med Chem 21:852-855
86. Wu ZQ, Belanger G, Brennan BB et al (2003) Targeting the transcriptional machinery with unique artificial transcriptional activators. J Am Chem Soc 125:12390-12391
87. Wu YL, Pandian GN, Ding YP et al (2013) Clinical grade iPS cells: need for versatile small molecules and optimal cell sources. Chem Biol 20:1311-1322
88. Yusa K, Rashid ST, Marchand HS et al (2011) Targeted gene correction of a1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478:391-394
89. Zhou Q, Li T, Price DH (2012) RNA polymerase II elongation control. Annu Rev Biochem 81:119-143